METSERA THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 15 Mar 2024)
What this means for you
This application is over — abandoned 01 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97809057
- Mark type
- Stylized text
- Filed
- 23 Feb 2023
- Abandoned
- 01 Mar 2024
- Attorney of record
- David Cole
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of pharmaceuticals; pharmaceutical preparations
- Class 009 — Scientific and electric apparatus: Medical software for the automated diagnosis of disease conditions from analysis of medical data
- Class 035 — Advertising and business services: Data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications
- Class 036 — Insurance and financial services: Providing healthcare administration, namely, providing insurance verification and prior authorization services for others; administration of patient reimbursement programs
- Class 042 — Scientific and technological services: Computer programming consultancy; Computer software consulting; Advanced product research in the field of artificial intelligence; Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare access to a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications; Scientific and technological services, particularly scientific research and analysis, in the fields of medicine, health and wellness; design and development of computers and software; biomedical research; software development; scientific laboratory services; provision of information relating to medical and scientific research in the field of pharmaceutical products; software programming; in the fields of medicine, health, fitness, exercise and wellness
Owner
- Population Health Partners, L.P., Short Hills, NJ, US
Prosecution history
- 15 Mar 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 15 Mar 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 29 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Nov 2023 — NON-FINAL ACTION E-MAILED
- 29 Nov 2023 — NON-FINAL ACTION WRITTEN
- 21 Nov 2023 — ASSIGNED TO EXAMINER
- 14 Mar 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Feb 2023 — NEW APPLICATION ENTERED